Header Molecular Tumor Diagnostics

Core Unit for Molecular Tumor Diagnostik

The Core Unit for Molecular Tumor Diagnostics (CMTD) is a research facility for the molecular characterization of sporadic and hereditary tumors based on next generation sequencing (NGS) techniques, bioinformatic analysis pipelines and interpretation of the results by experienced molecular pathologists and human geneticists. It is an essential and fundamental interface in the area of translational cancer research and clinical studies. The aim of the CMTD is the fast translation of novel molecular markers into clinical application by making indication-specific multi gene panels available. 

Service features

Project Request

Please fill out our project request form and send it back to:


Project Request (German)

Project Request (English)

Please keep the project title short and unique for your project. As project description 2-3 short sentences about your project are sufficient. All other fields are optional, but will help us and you for a better planning of your project.


Please contact us for consultation prior to sequencing projects. This will allow us to provide initial support in study design and therefore optimize the performance of the NGS experiments.

We offer high-throughput sequencing services, consultation and expert assistance in planning, sample preparation and method development.

Here are a few examples of what we offer:

[Translate to Englisch:] NCT Dresden Tumor-Diagnostikgruppe

A wide range of next-generation sequencing (NGS) applications are used in a targeted manner to provide comprehensive answers to medical questions. © TUD/Stephan Wiegand

State-of-the-art high-throughput sequencing is used to study the genetic material of patients and changes in tumors. © TUD/Stephan Wiegand


Alexander Krüger
Coordinator Core Unit for Molecular Tumor Diagnostics
Tel.: +49 (0)351 458 16857


Prof. Dr. med. Gustavo Baretton
Director of the Institute for Pathology
Co-Director Core Unit for Molecular Tumor Diagnostics
Tel.: +49 (0) 351 458 3000

Prof. Dr. med. Evelin Schröck
Director of the Institute for Clinical Genetics
Co-Director Core Unit for Molecular Tumor Diagnostics
Tel.: +49 (0) 351 458 5136

Medical and Scientific Coordinators

Prof. Dr. med. Daniela Aust
Medical Koordinator
Head of Molecular Pathology
Tel.: +49 (0)351 458 3004

Dr. rer. nat. Doreen William
Scientific Coordinator
Head of Molecular Genetic Research of the Institute for Clinical Genetics
Tel.: +49 (0)351 458 13914


Dr. rer. nat. Anja Kögler
Tel.: +49 (0)351 458 11745

Dr. rer. physiol. Thomas Groß
Tel.: +49 (0)351 458 11327

Rebecca Prause M.Sc.
Tel.: +49 (0)351 458 19904

Lisa Eckhardt M.Sc.
Tecnical Assistant
Tel.: +49 (0)351 458 19573

Enrico Zyball
Technical Assistant
Tel.: +49 (0)351 458 19621